Print
Email
Print Edition Stories
MHT's Julie Donnelly: Life science startups finding investments
MHT's Marc Songini: Technology to keep seniors healthy
MHT's Efrain Viscarolasaga: Tech companies may have to wait for stimulus funds
Shares in medical-technologies developer Bruker Corp. jumped almost 16 percent Thursday after the company released better than expected third quarter earnings figures.
Company CEO Frank Laukien stressed the company’s improved performance quarter-to-quarter, against the backdrop of a difficult environment for manufacturers of capital equipment.
“During the third quarter we have seen positive sequential trends in bookings throughout the company, even in the divisions with a greater industrial markets exposure. We have also begun to see robust bookings from our academic and government customers who are benefiting from various global government stimulus programs. While we expect a strong fourth quarter of 2009, we believe that most of the anticipated positive revenue and margin effects from global stimulus orders will be reflected in Bruker’s financial results in 2010 and 2011,” Laukien said in a prepared statement.
Bruker (Nasdaq:BRKR) was trading at $11.64 a share mid-day Thursday, up from $10.05 a share at the previous day’s close.
The Billerica-based scientific instrument maker reported revenue of $265.1 million for the third quarter ended Sept. 30, up from $242.1 million for the corresponding period last year.
Profit was down slightly on a year-over-year basis, dipping to $16.4 million from $17.8 million for the third quarter of 2008. Operating expenses remained relatively flat for the quarter, compared with 2008’s corresponding period.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
